Deep Track Capital, LP 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 08:41 am Sale | 2025-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Deep Track Capital, LP | 0 0.000% | -4,400,000 (Position Closed) | Filing |
| 2025-10-07 4:34 pm Purchase | 2025-09-30 | 13G | Akero Therapeutics, Inc. AKRO | Deep Track Capital, LP | 4,400,000 5.500% | 4,400,000 (New Position) | Filing |